Establishing meaningful change thresholds for European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire CLL‐specific module domain scores: An analysis based on the TRANSCEND CLL 004 study in patients with relapsed or refractory chronic lymphocytic leukaemia or small lymphocytic lymphoma

Autor: Laurie Eliason, Fatoumata Fofana, Lin Wang, Peter A. Riedell, Shien Guo

Publikováno v: eJHaem, Vol 5, Iss 6, Pp 1165-1172 (2024)

Abstract Introduction The study aimed to establish meaningful thresholds at patient and group levels for the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire CLL‐specific module (EORTC QLQ‐CLL17) domain sco

Externí odkaz: https://doaj.org/article/4bfdba0007214ed9b5ebfc27a2597a80

004. Confirming The Diagnosis of Hirschsprung Associated Enterocolitis Based on The Hirschsprung Associated Enterocolitis Guidelines: A Literature Review

Autor: Kemal Fadhli Hadi, Riana Pauline Tamba

Publikováno v: JBN (Jurnal Bedah Nasional), Vol 8, Iss 2, Pp S4-S4 (2024)

Background: Hirschsprung's disease (HD) is one of the most common causes of intestinal obstruction in neonates. One of the most frequently encountered complications, and the leading cause of morbidity and mortality in HD patients, is Hirschsprung-ass

Externí odkaz: https://doaj.org/article/8958874d4ec04d29989ebe581e325ddd

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

1 004 张中药饮片处方中细辛的使用情况及其治疗 皮肤疾病的临床应用分析.

Autor: 刘 倩¹ 15206065@qq.com, 梅全喜², 刘金伟¹, 张韶辉¹ 53685340@qq.com

Publikováno v: Evaluation & Analysis of Drug-Use in Hospitals of China. 2023, Vol. 23 Issue 1, p104-111. 5p.

Establishing meaningful change thresholds for European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire CLL-specific module domain scores: An analysis based on the TRANSCEND CLL 004 study in patients with relapsed or refractory chronic lymphocytic leukaemia or small lymphocytic lymphoma.

Autor: Eliason L; Worldwide HEOR, Patient Reported Outcomes Assessment, Bristol Myers Squibb Princeton New Jersey USA., Fofana F; Department of Clinical Outcome Analytics Evidera PPD Ede Netherlands., Wang L; Global Health Economics & Outcomes Research Headquarters Cell Therapy Bristol Myers Squibb Princeton New Jersey USA., Riedell PA; Department of Medicine David and Etta Jonas Center for Cellular Therapy University of Chicago Chicago Illinois USA., Guo S; Department of Clinical Outcome Analytics Evidera PPD Waltham Massachusetts USA.

Publikováno v: EJHaem [EJHaem] 2024 Oct 07; Vol. 5 (6), pp. 1165-1172. Date of Electronic Publication: 2024 Oct 07 (Print Publication: 2024).